Friedreich’s ataxia is a rare genetic disease that causes difficulty walking, a loss of sensation in the arms and legs, ... Your doctor may also order a CT or MRI scan.

Friedreich ataxia (FRDA) is the most common of the inherited ataxias, with an estimated prevalence of 3–4 cases per 100,000 individuals. There are, as yet, no robust evidence-based standards of ...

Hereditary ataxias, such as Friedreich’s ataxia, are genetic, meaning they are caused by "a defect in a certain gene that is present from the start of a person’s life, inherited from your ...

Friedreich’s ataxia (FA) is a neurodegenerative disease most people have never heard of, and it remains widely misunderstood —and for the hundreds of Canadians who live with it, the lack of ...

A total of 40 omaveloxolone patients and 42 placebo patients were included in the full analysis. At 48 weeks, changes from baseline in mFARS scores in the omaveloxolone group (-1.55 points) and ...

PTC Therapeutics (PTCT) submitted the vatiquinone New Drug Application, or NDA, for the treatment of children and adults living with Friedreich ataxia, or FA, to the FDA. The vatiquinone NDA is ...

Key Takeaways. Treatment goals for Friedreich ataxia include symptom management, slowing disease progression, and enhancing quality of life through multidisciplinary care.